{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:54:08Z","timestamp":1791579248803,"version":"4.3.4"},"reference-count":120,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Clin Exp Hematol"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p>Despite the advances in our knowledge of myeloma cell biology, our understanding of myeloma pathogenesis is still incomplete. In this review, we present a summary of the cellular and molecular aspects of B\u2010cell development and immunoglobulin (Ig) gene rearrangement which have been important in defining the characteristics of the myeloma plasma cell (MPC). The PMC has undergone variable gene recombination, somatic hypermutation and isotype switching, and is therefore at a postgerminal center stage of development. The finding of preswitch clonal cells and isotype variants have raised interesting questions about the cell of origin of myeloma, for which no conclusive data is as yet available. However much information has been obtained about the chromosomal and genetic aberrations in myeloma, including monosomy 13, Ig heavy chain (IgH) switch region translocations, numerical abnormalities and a multitude of heterogeneous changes. A variety of techniques have been developed to overcome the insensitivity of conventional karyotyping, utilizing molecular cytogenetic strategies ranging from the delineation of precise loci by fluorescent in situ hybridization, a more \u201cglobal\u201d assessment of the genome by multicolor spectral karyotyping, to the quantitation of chromosomal material of specific origin by comparative genomic hybridization. Whether the abnormalities detected represent oncogenic insults, are involved in disease progression or are simply \u201cby\u2010products\u201d of genetic instability is still unclear. For IgH translocations, the role of candidate genes such as Cyclin D1 and FGFR3 has been studied extensively by quantitating their expression and assessment of their oncogenicity (e.g. for FGFR3) in animal models. The significance of other aberrations such as c\u2010myc, ras and p53 has also been investigated. With the advent of oligonucleotide microarrays, the expression of thousands of genes can be efficiently examined. So far, this approach seems promising in defining subgroups of different disease behavior, and may highlight specific genes and molecular mechanisms which are important in myeloma pathogenesis.<\/jats:p>","DOI":"10.1046\/j.1468-0734.2002.00081.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T19:09:12Z","timestamp":1047496152000},"page":"276-300","source":"Crossref","is-referenced-by-count":20,"title":["T<scp>HE<\/scp> B<scp>IOLOGY<\/scp><scp> AND<\/scp> C<scp>YTOGENETICS<\/scp><scp>OF<\/scp> M<scp>ULTIPLE<\/scp> M<scp>YELOMA<\/scp>"],"prefix":"10.1111","volume":"6","author":[{"given":"P. Joy","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80453-5"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90077-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/376263a0"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/44076"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.3.969"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90293-L"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830211209"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.1995.tb55818.x","article-title":"Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation.","volume":"764","author":"Malisan F","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/342929a0"},{"key":"e_1_2_7_11_2","first-page":"29","volume-title":"Myeloma: Biology and Management","author":"MacLennan ICM.","year":"1998"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059611"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.13931"},{"key":"e_1_2_7_14_2","first-page":"1","volume-title":"Molecular Immunology","author":"Blackwell TK","year":"1989"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","article-title":"Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.","volume":"80","author":"Bakkus MH","year":"1992","journal-title":"Blood"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V82.1.202.bloodjournal821202","article-title":"Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B\u2010cell clone: evidence from the Ig heavy chain gene.","volume":"82","author":"Ralph QM","year":"1993","journal-title":"Blood"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04872.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07530.x"},{"key":"e_1_2_7_19_2","first-page":"8563","article-title":"A new human immunoglobulin VH family preferentially rearranged in immature B\u2010cell tumours.","volume":"84","author":"Humphries C","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb00285.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood.V87.7.2846.bloodjournal8772846","article-title":"VH gene usage in multiple myeloma: complete absence of the VH4.21 (VH4\u201034) gene.","volume":"87","author":"Rettig MB","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V92.8.2844","article-title":"A high frequency of circulating B cells share clonotypic Ig heavy\u2010chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single\u2010cell and in situ reverse transcriptase\u2010polymerase chain reaction.","volume":"92","author":"Szczepek AJ","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2791"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402164"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<630::AID-CNCR2820440233>3.0.CO;2-G"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis.","volume":"66","author":"Dewald GW","year":"1985","journal-title":"Blood"},{"key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.V85.9.2490.bloodjournal8592490","article-title":"Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.","volume":"85","author":"Lai JL","year":"1995","journal-title":"Blood"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05593.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2073.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00951.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01181.x"},{"key":"e_1_2_7_32_2","first-page":"153","article-title":"Incidence of chromosome numerical changes in multiple myeloma.","volume":"149","author":"Tabernero D","year":"1996","journal-title":"Am J Pathol"},{"key":"e_1_2_7_33_2","first-page":"2109","article-title":"Interphase fluorescence in situ hybridisation (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.","volume":"9","author":"Flactif M","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_7_34_2","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridisation.","volume":"55","author":"Drach J","year":"1995","journal-title":"Canc Res"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V94.2.724","article-title":"Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double\u2010color fluorescent in situ hybridization.","volume":"94","author":"Finelli P","year":"1999","journal-title":"Blood"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0496-368"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5274.494"},{"key":"e_1_2_7_39_2","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1182\/blood.V92.11.4269","article-title":"Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.","volume":"92","author":"Sawyer JR","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02546.x"},{"key":"e_1_2_7_41_2","first-page":"1743","article-title":"Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.","volume":"92","author":"Rao PH","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_42_2","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","article-title":"Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization.","volume":"91","author":"Cigudosa JC","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402116"},{"key":"e_1_2_7_44_2","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.","volume":"86","author":"Tricot G","year":"1995","journal-title":"Blood"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1997.4616"},{"key":"e_1_2_7_46_2","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.","volume":"95","author":"Zojer N","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1566"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.804"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00657.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","article-title":"Results of high\u2010dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.","volume":"95","author":"Desikan R","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1271"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02488.x"},{"key":"e_1_2_7_53_2","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma.","volume":"59","author":"Avet\u2010Loiseau H","year":"1999","journal-title":"Canc Res"},{"key":"e_1_2_7_54_2","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome.","volume":"94","author":"Avet\u2010Loiseau H","year":"1999","journal-title":"Blood"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059651"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049739"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1322949.x"},{"key":"e_1_2_7_59_2","first-page":"733","article-title":"A molecular classification of multiple myeloma based on cytogeneic abnormalities detected by interphase FISH is powerful in identifying discrete groups of patients with dissimilar prognosis (Abstract).","volume":"98","author":"Fonseca R","year":"2001","journal-title":"Blood"},{"key":"e_1_2_7_60_2","unstructured":"Shaughnessy J Barlogie B McCoy J et al.Early relapse after total therapy II for multiple myeloma is significantly associated with cytogenetic abnormalities of chromosome 13 but not with interphase FISH\u2010del 13 or plasma cell labeling index (Abstract).Blood98: 734a 2001."},{"key":"e_1_2_7_61_2","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V84.7.2283.2283","article-title":"Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia","volume":"84","author":"Taniwaki M","year":"1994","journal-title":"Blood"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609067575"},{"key":"e_1_2_7_63_2","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4:14)(p16;q32) in patients with plasma cell malignancies.","volume":"58","author":"Avet\u2010Loiseau H","year":"1998","journal-title":"Canc Res"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00700.x"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65022-5"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1309\/4W8E-8F4K-BHUP-UBE7"},{"key":"e_1_2_7_67_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.","volume":"88","author":"Chesi M","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_68_2","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited.","volume":"60","author":"Sherr CJ.","year":"2000","journal-title":"Canc Res"},{"key":"e_1_2_7_69_2","first-page":"2691","article-title":"Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).","volume":"95","author":"Janssen JWG","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-260"},{"key":"e_1_2_7_71_2","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","article-title":"A novel chromosomal translocation t(4;14) (p16.3;q32) in multiple myeloma involves the fibroblast growth\u2010factor receptor 3 gene.","volume":"90","author":"Richelda R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_72_2","first-page":"4058","article-title":"Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription\u2010polymerase chain reaction analysis of IGH\u2010MMSET fusion transcripts.","volume":"60","author":"Malgeri U","year":"2000","journal-title":"Canc Res"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.8.4081"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0696-233"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.729"},{"key":"e_1_2_7_76_2","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V92.8.2987","article-title":"FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma.","volume":"92","author":"Fracchiolla NS","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02957.x"},{"key":"e_1_2_7_78_2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood.V95.3.992.003k29_992_998","article-title":"Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.","volume":"95","author":"Plowright EE","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_79_2","first-page":"2262","article-title":"Prevention of myeloma cell apoptosis by ectopic bcl\u20102 expression or interleukin 6\u2010mediated up\u2010regulation of bcl\u2010xL.","volume":"55","author":"Schwarze MM","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204465"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.10.6621"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.8.2413"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.7.1071"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0498-331"},{"key":"e_1_2_7_85_2","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in Igh\/MMSET hybrid transcripts.","volume":"92","author":"Chesi M","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204641"},{"key":"e_1_2_7_87_2","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457.412k48_4457_4463","article-title":"Frequent dysregulation of the c\u2010maf proto\u2010oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.","volume":"91","author":"Chesi M","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_88_2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/jvi.67.4.2133-2141.1993","article-title":"Structure\u2010function analysis of the maf oncogene product, a member of the b\u2010Zip protein family.","volume":"67","author":"Kataoka K","year":"1993","journal-title":"J Virol"},{"key":"e_1_2_7_89_2","first-page":"2140","article-title":"WWOX, a novel WW domain\u2010containing protein mapping to human chromosome 16q23.3\u201324.1, a region frequently affected by breast cancer.","volume":"60","author":"Bednarek AK","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-226"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5299.540"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401563"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.217"},{"key":"e_1_2_7_94_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.3082"},{"key":"e_1_2_7_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00109-1"},{"key":"e_1_2_7_96_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111763200"},{"key":"e_1_2_7_97_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.2.490"},{"key":"e_1_2_7_98_2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V90.2.526","article-title":"The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.","volume":"90","author":"Nishida K","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_99_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.822"},{"key":"e_1_2_7_100_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V88.1.289.289","article-title":"Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.","volume":"88","author":"Billadeau D","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1091"},{"key":"e_1_2_7_102_2","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V86.10.3915.bloodjournal86103915","article-title":"Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance.","volume":"86","author":"Drach J","year":"1995","journal-title":"Blood"},{"key":"e_1_2_7_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X"},{"key":"e_1_2_7_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)00284-I"},{"key":"e_1_2_7_105_2","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","article-title":"Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes.","volume":"91","author":"Perez\u2010Simon JA","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_106_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2229"},{"key":"e_1_2_7_107_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3140713"},{"key":"e_1_2_7_108_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.228"},{"key":"e_1_2_7_109_2","first-page":"2119","article-title":"Correlations between karyotype and cytologic findings in multiple myeloma.","volume":"9","author":"Weh HJ","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_7_110_2","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V91.5.1732","article-title":"Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.","volume":"91","author":"Sawyer JR","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_111_2","doi-asserted-by":"publisher","DOI":"10.1159\/000133022"},{"key":"e_1_2_7_112_2","first-page":"277","article-title":"Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non\u2010random abnormality that is frequently associated with Burkitt\u2019s\u2010type translocations.","volume":"9","author":"Mugneret F","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_7_113_2","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood.V91.6.1873","article-title":"Molecular cloning of translocation t(1;14) (q21;q32) defines a novel gene (BCL9) at chromosome 1q21.","volume":"91","author":"Wills TG","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08253.x"},{"key":"e_1_2_7_115_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional\u2010dose chemotherapy.","volume":"92","author":"Drach J","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_116_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V81.1.128.128","article-title":"p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.","volume":"81","author":"Neri A","year":"1993","journal-title":"Blood"},{"key":"e_1_2_7_117_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.5.1715"},{"key":"e_1_2_7_118_2","first-page":"3640","article-title":"Introduction of an activated N\u2010ras oncogene alters the growth characteristics of the interleukin 6\u2010dependent myeloma cell line ANBL6.","volume":"55","author":"Billadeau D","year":"1995","journal-title":"Canc Res"},{"key":"e_1_2_7_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/4447"},{"key":"e_1_2_7_120_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1745"},{"key":"e_1_2_7_121_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5334.1948"}],"container-title":["Reviews in Clinical and Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-0734.2002.00081.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-0734.2002.00081.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T17:19:30Z","timestamp":1697563170000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-0734.2002.00081.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1046\/j.1468-0734.2002.00081.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-0734.2002.00081.x","archive":["Portico"],"relation":{},"ISSN":["1127-0020","1468-0734"],"issn-type":[{"value":"1127-0020","type":"print"},{"value":"1468-0734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}